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All solid organs contain resident monocyte-derived cells that appear early in organogenesis and persist throughout life. These cells are critical for
normal development in some organs. Here we report the use of a previously described transgenic line, with EGFP driven by themacrophage-restricted
Csf1r (c-fms) promoter, to image macrophage production and infiltration accompanying organogenesis in many tissues. Using microarray analysis of
FACS-isolated EGFP-positive cells, we show that fetal kidney, lung and brainmacrophages show similar gene expression profiles irrespective of their
tissue of origin. EGFP-positive cells appeared in the renal interstitium from 12 days post coitum, prior to nephrogenesis, and maintain a close
apposition to renal tubules postnatally. CSF-1 added to embryonic kidney explants increased overall renal growth and ureteric bud branching.
Expression profiling of tissue macrophages and of CSF-1-treated explants showed evidence of the alternate, pro-proliferative (M2) activation profile,
including expression of macrophage mannose receptor (CD206), macrophage scavenger receptor 2 (Msr2), C1q, CD163, selenoprotein P, CCL24
and TREM2. This response has been associated with the trophic role of tumour-associated macrophages. These findings suggest a trophic role of
macrophages in embryonic kidney development, which may continue to play a similar role in postnatal repair.
© 2007 Elsevier Inc. All rights reserved.Keywords: Embryonic macrophage; Expression profiling; Colony-stimulating factor 1 (CSF-1); Csf1R; c-fms; Kidney development; Organogenesis; EGFP
transgene; Alternate macrophage activationIntroduction
During mammalian development, specialized phagocytic
cells are formed in the yolk sac and rapidly infiltrate the embryo
via the developing vasculature. As definitive haematopoiesis is
established in the liver, a distinct set of phagocytes, the
monocyte–macrophages of the adult, are formed (Lichanska et
al., 1999; Lichanska and Hume, 2000; Shepard and Zon, 2000).⁎ Corresponding author. Fax: +61 7 3346 2101.
E-mail address: m.little@imb.uq.edu.au (M.H. Little).
1 Equal contribution was made by these authors.
2 Current address: Eijkman Institute for Molecular Biology Jl., Diponegoro 69
akarta 10430, Indonesia.J0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.05.027A major function of phagocytic cells in development is to clear
dying cells. Consequently, a lack of macrophages during this
period causes developmental problems, especially in brain and
lung (Henson and Hume, 2006; Li et al., 2005; Wood et al.,
2000). In mammals, the production of macrophages by the liver,
and subsequently by the bone marrow, is controlled in large part
by the growth factor macrophage colony-stimulating factor
(CSF-1). CSF-1 acts on its target cells by binding to colony-
stimulating factor 1 receptor (Csf1r), a cell-surface tyrosine
kinase receptor encoded by the c-fms proto-oncogene, which is
expressed in macrophage and trophoblast cell lineages (Chitu
and Stanley, 2006; Stanley et al., 1997; Sweet and Hume,
2003). Csf1r is critical for the proliferation, survival and dif-
ferentiation of macrophages as disruption of the gene results in
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2002). Upon reaching a tissue compartment from the blood-
stream, monocytes differentiate into resident tissue macro-
phages. Resident macrophage populations adapt to their local
environment resulting in dramatically different phenotypes in
different organs, for example Langerhans cells (skin), Kupffer
cells (liver), microglia (brain) and osteoclasts (bone) (Gordon
and Taylor, 2005; Hume, 2006).
The localization of c-fms (Csf1r) mRNA by whole mount in
situ hybridization has been used to assess the appearance of
embryonic phagocytes in the mouse yolk sac, and the
subsequent onset of monocytopoiesis in the liver (Hume et
al., 1995; Lichanska et al., 1999). The early embryonic
phagocytes are distinct from adult macrophages in their
expression of a number of key receptors, in their independence
of the macrophage-restricted transcription factor, PU.1
(Lichanska et al., 1999), and the fact that they do not apparently
arise through a classical monocyte intermediate (Lichanska and
Hume, 2000). There are no mice that lack macrophages
altogether, but the phenotypes of c-fms, CSF-1 and PU.1-
mutant animals all imply that there are essential trophic roles
played by these cells in the development of multiple organ
systems (Cohen et al., 1996; Dai et al., 2002; Geutskens et al.,
2005; Michaelson et al., 1996; Van Nguyen and Pollard, 2002).
Macrophages are also implicated in tissue repair in adults. In
models of acute damage to muscle, liver, lung, gastrointestinal
tract and peripheral nervous system, infiltration by macro-
phages and production of macrophage-derived trophic factors,
appears to be absolutely essential for regeneration (Abe et al.,
2004; Berezovskaya et al., 1995; Kluth et al., 2004; Park and
Barbul, 2004; Pull et al., 2005). However, macrophages are the
classical two-edged sword. During chronic inflammation or a
disease setting associated with severe progressive injury,
macrophages are the dominant cell type implicated directly in
cell death and tissue damage.
To gain an insight into the possible role of macrophages in
development we have performed the first molecular profiling of
these resident embryonic macrophages and have examined the
effect of manipulation of their function in vitro. We have
previously described a transgenic mouse in which the Csf1r
promoter drives expression of an EGFP reporter gene (Sasmono
et al., 2003). Here, we show that this reporter gene is expressed
in, and restricted to, macrophage populations throughout
development and recapitulates the previously reported expres-
sion pattern of Csf1r mRNA. We also show that the EGFP
marker can be used to isolate macrophages from mouse
embryos and that these cells have a distinctive mRNA
expression profile. Finally, we demonstrate the potential trophic
role of macrophages in organogenesis through administration of
CSF-1 to renal explant cultures in vitro.
Materials and methods
Isolation and preparation of tissue for confocal analysis
All animal experimentation was approved by an institutional Animal Ethics
Committee (AEEC3, University of Queensland). Male transgenic mice ex-
pressing either enhanced green fluorescence protein (EGFP) (Sasmono et al.,2003) or enhanced cyan fluorescent protein (ECFP) (Ovchinnikov, unpublished
observations) driven from the Csf1r promoter were mated to CD1 outbred
females. Pregnant females were sacrificed at 11.5, 12.5, 15 dpc and newborn.
Transgenic offspring were determined by visualization of placental EGFP or
ECFP expression. Transgenic tissues were dissected separately in ice-cold PBS,
fixed in 4% paraformaldehyde (PFA) for 3 h, room temperature then equilibrated
in 30% sucrose overnight at 4 °C before mounting in Tissue-Tek OCT medium
in isopentane cooled over dry ice.
Immunofluorescence analysis
Light and confocal microscopy was used for fluorescence visualization of c-
fms–EGFP–macrophages in kidneys from 11.5 dpc, 12.5 dpc, 13.5 dpc,
15.5 dpc, 18.5 dpc and adult tissue. Following 4% PFA fixation, frozen sections
were cut at 5 μm using a cryostat (Leica, Bensheim, Germany) and visualized
under an Olympus Provis AX70 fluorescent microscope. Immunofluorescence
staining used the following antibodies; rat anti-mouse F4/80 (Serotec, Oxford,
UK), rabbit anti-aquaporin-1 (Chemicon, Temecula, CA) and anti-mouse
calbindin-D28K (Sigma Chemical Company, MI, USA). Where mouse primary
antibodies were used, kidney sections were incubated with M.O.M.™ blocking
diluent (Vector Laboratories, Burlingham, CA) before addition of primary
antibody. Goat anti-rat Alexa Fluor 594, goat anti-rabbit Alexa Fluor 594, and
goat anti-mouse Alexa Fluor 488 (all fromMolecular Probes, Eugene, OR) were
used to visualize F4/80, aquaporin-1 and calbindin, respectively. Sections were
mounted with a fluorescent mounting media (DakoCytomation) before
visualization with a Fluoview 1000 confocal microscope (Olympus, Tokyo,
Japan), FV10-ASW software (version 1.3c; Olympus), step size at 0.5 μm when
serial confocal microscopy analysis was applied.
Isolation of kidney, lung and brain embryonic tissue and macrophages
Tissues were harvested as above. 10–20 kidneys, 10 lungs or 10 brains were
incubated in 1 ml Dissociation Media (1 mg/ml collagenase B, 1.2 U/ml dispase,
5 U/ml DNase II, in HANKS media) at 37 °C for 20 min. Organs were manually
titrated with a P-1000 and incubated for a further 5 min at 37 °C. This step was
repeated before the organs were dissociated with a 23-gauge syringe and passed
through a 40 μM cell strainer (BD Bioscience). An equal volume of ice-cold
PBS was washed through the strainer and the cells were centrifuged at 3000 rpm
for 5 min. The supernatant was discarded and the cells resuspended in 2–3 ml of
ice-cold PBS. Cells were passed again through a 40-μm cell strainer, checked
under a microscope to ensure they were a single-cell suspension, and stored on
ice ready for fluorescence activated cell sorting (FACS). Isolation of EGFP
positive macrophages was carried out on a FACSVantage SE DiVa flow
cytometer (BD Biosciences). Approximately 200 transgenic kidneys /100
lungs / 100 brains were subjected to FACS analysis with non-transgenic
littermate kidneys used as a reference. Isolated macrophages were washed
with ice-cold PBS and stored at −70 °C in preparation for RNA extraction.
Samples of aliquoted cells were routinely re-run through the FACS machine to
confirm purity and the GFP+ status of the cells. Animal experimentation was
covered by Animal Ethics Committee number IMB/479/03/NIH.
Immunophenotypic confirmation of the specificity of the Csf1r–EGFP
reporter
To examine the specificity of the Csf1r–EGFP reporter, immunophenotypic
analysis of the GFP-positive cells isolated using FACS from postnatal Csf1r–
EGFP kidneys was performed. This analysis showed that 100% of the cells were
positive for both EGFP and CD45 and up to 75% of the cells were positive for
both EGFP and F4/80, which is present on a major sub-population of the Csf1r-
positive monocytic fraction in the mouse embryo (Lichanska et al., 1999). Only
0.02% of the GFP+CD45+ cells were CD11c+, suggesting a very low number of
GFP+ dendritic cells. We have also used two pericyte markers, monoclonal anti-
α-smooth muscle actin Cy3 conjugate (Sigma-Aldrich, St Louis, MO; 1:1000
dilution) and CD31–APC conjugate (PharMingen, BD Biosciences, USA), to
show that the GFP+ cells are not pericytes. These results suggest that there is
limited heterogeneity and that the majority of the cells isolated based on EGFP
expression are monocytic.
Fig. 1. Examination of transgene expression in yolk sac and embryo proper. (A–D) Whole mounts of yolk sacs from conceptuses at 9.5 dpc (A), 10.5 dpc (B) and
12.5 dpc (C). No green fluorescent cells could be observed in wildtype yolk sacs shown at 12.5 dpc (D). (E–N) Transgene expression in the embryo proper. Panel E
shows the presence of EGFP-positive cells (arrows) in the limb bud of the 9.5 dpc embryo. Awhole mount examination of 10.5 dpc embryos observed the presence of
EGFP-positive cells throughout the body, such as shown in the dorsal area of the embryo (F), around the umbilical cord (G) and in the mandibular arches (H). In
10.5 dpc embryo sections, green fluorescent cells were prominent in the liver (I), developing brain (J) and in the thymus area (K). EGFP-expressing cells were detected
in the aorta–gonad–mesonephros (AGM) area. Fluorescent (L) and bright field (M) images of sagittal sections through the dorsal aorta (da) of the 10.5 dpc embryo
revealed EGFP-positive cells. More prominent accumulation of green fluorescent cells was apparent in the transverse section through the AGM area of an 11.5 dpc
embryo (N), particularly in the mesonephric tubules (mes).
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Total RNA was isolated using an RNeasy Mini Kit (Qiagen). RNA was
subject to one round of amplification using the Amino Allyl MessageAmp RNA
Kit (Ambion) as previously described (Challen et al., 2005). Briefly, 5 μg of
control kidney, lung or brain tissue and 1.2 μg of macrophage total RNA was
reverse-transcribed into cDNA using a T7 Oligo(dT) primer. In vitro
transcription was then performed to generate antisense RNA (aRNA) containing
amino allyl UTP nucleotide in place of UTP. The integrity of the aRNA was
assessed by agarose gel electrophoresis and quantified by spectrophotometry.
5 μg of each sample was labeled via a coupling reaction using Cy3- or Cy5-
reactive dyes (Amersham Biosciences). Following fragmentation of the labelled
probe, hybridization to microarray slides was performed at 42 °C for 18 h. Each
pairwise comparison (e.g. kidney macrophage vs. kidney; kidney macrophage
vs. brain macrophage) experiment was performed in triplicate, including a dye
reversal replicate. Compugen murine oligonucleotide microarray chips (22K
elements, 65-mer oligos, visit http://www.labonweb.com/chips/libraries.html)
were printed at the SRC Microarray Facility, University of Queensland (http://
microarray.imb.uq.edu.au). Data values of gene expression levels were uploaded
into BASE 1.2.10 and normalized. Genes were then analysed using a B-score
statistic whereby genes with a B-score N0 have a N50% probability of being
differentially expressed.
RNA in situ hybridization
Section RNA in situ hybridization was performed as previously described
(Roche DIG Application Manual; 31) with minor modifications. Sections were
dehydrated through an ethanol series prior to hybridization overnight at 65 °C.
Post-hybridization washes consisted of 6×SSC (5 min, 65 °C), 2×SSC/50%
formamide/10 mM EDTA (30 min, 65 °C), 2×SSC (2×30 min, 65 °C) and
0.2×SSC (2×30 min, 65 °C).
Kidney explant culture
Metanephric organ culture was used to test the effects of CSF-1, CCL4 and
CCL9, CCL6, Cxcl1 and Gas6 on the developing metanephros. Metanephroi
from 11.5 dpc mice were grown for 1–4 days on Poretics 13-mm polycarbonate
inserts (Osmonics Inc.) with a membrane pore size of 1.0 μm at 37 °C with 5%
CO2 in 300 μl of DMEM/Hams F12 media (Invitrogen) supplemented with
50 μg/ml transferrin and 20 mM glutamine. Recombinant CSF-1 (Chiron) was
added to a final concentration of 100 U/μl with LPS at (0.1–10 ng/ml). CCL4,
CCL9, CCL6, Cxcl1, Gas6 (R&D Systems) were added at between 5 and
500 ng/ml. Data is presented for CSF-1 at 100 ng/ml. Co-immunofluorescence
for calbindin-D28K (Sigma Chemical Company) and WT1 (Santa Cruz, SC-
192) was performed to visualize the ureteric epithelium and early nephrons
respectively, as previously described (Piper et al., 2002). Digital images were
captured using a Dage “MTI” peltier cooled charge coupled device digital
camera attached to an AX70 Olympus microscope, and processed using Adobe
Photoshop 7 software. To semi-quantitatively assess the effects of these factors
on in vitro metanephric development, branch tips and WT1-positive bodies
(forming nephrons) present in each explanted metanephros were counted.
Experiments were repeated at least twice with a total of between 8 and 10
metanephroi per experiment. As there is considerable variation between
different litters in the stage of metanephric development present at isolation, a
representative set of data from one experiment is presented with error bars
representing the ±standard error of the mean. A one-way ANOVA followed by a
Tukey's post-hoc test was used to assess significance.Results
Population of the developing mouse with Csf1r–EGFP
expressing cells
In the original description of the Csf1r–EGFP transgene,
there was a limited examination of the expression in the embryo(Sasmono et al., 2003). Figs. 1–3 demonstrate that the EGFP
reporter provides a unique and convenient marker for the
appearance of macrophages during mouse embryonic develop-
ment. EGFP-positive cells were first detectable in the yolk sac
around 9–9.5 dpc (Figs. 1A–D). There was no obvious
clustering of these cells around blood islands or any other
structure, consistent with earlier reports that the yolk-sac-
derived macrophages do not arise from conventional mono-
cytopoiesis (Lichanska and Hume, 2000). At 9–9.5 dpc, the first
EGFP-positive cells were also observed in the embryo proper
(Figs. 1E–N). This was followed by a very rapid wave of
migration occurring within a 24-h window. The numbers of
EGFP-positive cells, their morphology and distribution in the
yolk sac remain relatively constant through to 15.5 dpc, the
latest time point examined. During embryonic haematopoiesis,
the aorta–gonad–mesonephros (AGM) region becomes popu-
lated with haematopoietic progenitors (Dzierzak, 2003; Yoder,
2001). In 10.5 dpc embryos, sagittal sections through the dorsal
aorta and its vicinity revealed the first EGFP-positive cells
(Figs. 1L–N), some scattered within the mesenchyme and
others present in the lumen of the aorta amongst the red blood
cells, suggesting that they are arriving via the circulation. By
11.5 dpc, a transverse section clearly revealed the accumulation
of clusters of fluorescent cells, particularly associated with the
mesonephric tubules (Fig. 1N). The extensive infiltration of this
region by EGFP-positive cells was especially evident in whole
mounts of the 11.5 dpc genital ridge and dorsal aorta (Fig. 2D).
Morphologically, cells in this region appeared smaller and more
rounded than the stellate macrophages of the yolk sac and other
parts of the embryo. As Csf1r is expressed on pluripotent
progenitors cells (Tagoh et al., 2002), we suggest that the EGFP
reporter is providing a unique marker for the macrophage
population of the AGM. Progenitor cells in this region differ
from those in fetal liver and adult in that they lack CD45
(Bertrand et al., 2005a), but their expression of Csf1r has not
been reported. Elsewhere in the embryo, EGFP-positive cells
were already a prominent population by 10.5 dpc (Figs. 1F–K).
They were especially numerous and ramified in the developing
brain (Fig. 1J), mandibular arches (Fig. 1H) and thymic anlage
(Fig. 1K).
By 11.5 dpc, a high density of cells clustered around the
reticulating vasculature of the head (Figs. 2A, B). Fig. 2C shows
the continued increase in the developing limb. By the time the
first large-scale cell death is observed, EGFP-positive cells
appear concentrated under the apical ectodermal ridge (Fig. 2C)
and in the anterior necrotic zone (not shown). In the AGM, there
is a dense cluster of EGFP-positive cells (Fig. 2D). Fig. 2E
shows the large numbers of macrophages that infiltrate the
developing lens at this stage of embryonic development
(Nishitani and Sasaki, 2006). Based upon the proportional
area of any section that is positive for the marker, we estimate
that EGFP-positive cells represent 3–10% of total cells in most
parts of the embryo at this stage of development. At 13.5 dpc
(Figs. 2G–L), a striking concentration of Csf1r–EGFP-positive
cells was observed in the thymic anlage (Fig. 2H). There is little
published work on myeloid population of the thymus at this
early development stage, although the role of macrophages in
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Fig. 3. Analysis of the arrival and final location of EGFP-positive cells in the permanent kidney (metanephros). (A–D) Confocal analysis of sections of 12.5 dpc mouse
kidney showing expression of the macrophage marker F4/80 (A, red), EGFP (B, green), calbindin 28 kDa (C, pink) and a merge of these three channels with a bright
field image of the same section (scale bar=300 μm). Calbindin 28 kDa indicates the location of the ureteric bud. Black arrows indicate macrophages positive for both
F4/80 and EGFP (D). (E, F) Whole metanephroi dissected from 11.5 dpc Csf1r–ECFP transgenic mice shown both as bright field (E) and fluorescence images (F,
detecting ECFP). A dotted line shows the outline of the metanephros and the location of the ureter. Developing vasculature can be seen along the metanephros (white
arrows), showing the relative location of the macrophages to the circulation (F). Localization of resident macrophages in the adult kidney. (G) Bright field with EGFP
fluorescence overlay of section of adult kidney cortex showing macrophages between the tubules. (H) Immunolocalization of aquaporin-1 to proximal tubular
epithelial cells (red) and EGFP overlay of adult kidney cortex showing the relative location of the resident macrophage in relationship to the proximal tubules by
confocal microscopy. (I–K) Immunofluorescence of E16 mouse kidney showing EGFP (I), F4/80 (J) and a merge (K) illustrating the coexpression of the F4/80
macrophage marker with the EGFP transgene expression. (L) FACS-based isolation of renal macrophages from the 15.5 dpc kidneys of Csf1r–EGFP mice showing
that EGFP-positive cells in the transgenic animals represents 2.8% of the total. (M–P) Three colour light microscopic analysis of the adult kidney showing
immunofluorescence for aquaporin-1 (M, red), fluorescence of EGFP-positive macrophages (N, green), DAPI-stained nuclei (O, blue), and a merged image (P).
237F. Rae et al. / Developmental Biology 308 (2007) 232–246thymocyte phagocytosis later in development is clear (Ander-
son et al., 2000; Henson and Hume, 2006). The exceptionally
high density of Csf1r–EGFP positive cells in the thymic anlageFig. 2. (A–F) Csf1r–EGFP in 11.5 dpc embryos. On examination of whole mount em
as shown in the superficial tissues of the head with prominent green cells clustered a
dashed line). Numerous green cells could be seen in the limb bud (C, arrows) with a s
in the AGM were also EGFP-positive (D, arrow). Panel E shows a section through
accumulation of green fluorescent cells. (G–L) EGFP examination in 13.5 dpc em
distributed in the parenchyma of the liver (G) and the thymus area (H). Embryonic ph
the interdigital areas of the developing footplate. In whole mounts of Csf1r–EGFP em
these regions (I, arrows). These cells could also be seen in the tail vein (J). In cultured
G, developing gonad; M, mesonephros. (M–P) Examination of 15.5 dpc embryo sec
concentrated in the mesenchymal tissue separating the nasal septal cartilage and the ol
epithelium (arrow, N). In the embryo, osteoclasts expressed EGFP, as shown around th
the choroid layer beneath the pigment layer of the retina (P).prior to the arrival of T lymphocytes clearly implicates these
cells as key players in the development of the thymus. There is
also a striking infiltration in the vicinity of the olfactorybryos, numerous EGFP-positive cells were distributed throughout the body, such
round the blood vessels (A, dashed line) which could be seen in bright field (B,
trong accumulation evident under the apical ectodermal ridge (AER). Many cells
the 11.5 dpc lens vesicle (lv). An embryo section through the liver (F) shows
bryos. Extensive accumulation of EGFP-positive cells could be seen evenly
agocytes are well known for their role in clearance of apoptotic cells as occurs in
bryos, extensive accumulations of EGFP-positive cells were clearly observed in
organs, green fluorescent phagocytes were seen in the kidney (K) and ovary (L).
tions. Panel M shows the nasal septum region, showing the EGFP-positive cells
factory epithelium. In some areas, green fluorescent cells infiltrated the olfactory
e humerus (O). In the developing eye, EGFP-expressing cells were prominent in
238 F. Rae et al. / Developmental Biology 308 (2007) 232–246epithelium (Figs. 2M, N), which has emerged as a possible
source of adult stem cells. Our observation suggests that the
claim that haematopoietic stems cells are unlikely to be found in
this location (Murrell et al., 2005) should be viewed with
caution. Additional images from later stages of development
(12.5 dpc, 13.5 dpc, 15.5 dpc) can be viewed on our web site at
www.macrophages.com.
Macrophage recruitment in response to CSF-1 has been
shown to have an essential function in the ductal outgrowth in
the developing mammary gland (Van Nguyen and Pollard,
2002). To look for additional roles of infiltrating macrophages
during organogenesis, we focused on another well-studied
example of branching morphogenesis, the developing kidney.
In the kidney, organogenesis involves the infiltration of the
metanephric mesenchyme by the ureteric bud and subsequent
branching morphogenesis and mesenchymal-to-epithelial tran-
sition to produce a functional nephron (Saxen, 1987). Using
confocal analysis of kidneys from the Csf1r–EGFP mice,
EGFP-positive cells were first detected within the kidney
between 11.5 and 12 dpc (Figs. 3A–F) and infiltrated the renal
interstitium. Figs. 3A–D demonstrates the co-localization of
F4/80, a marker of mature macrophages, in EGFP-positive
cells in the interstitium surrounding the ureteric bud. Using
Csf1r–ECFP mice, which have a higher level of fluorescence,
ECFP-positive cells surrounding the dissected 11.5 dpc
metanephros appeared to be closest to the developing vascular
bed between the metanephric mesenchyme and the metaneph-
ric duct (Figs. 3E, F), suggesting that the macrophages enter
the renal mesenchyme from or with the circulation at around
this time. As the tubules of the developing nephrons arise and
the interstitial space contracts, the renal macrophages become
intimately associated with the basement membranes of the
adjacent proximal and distal tubules (Figs. 3G–K). Their
cellular processes wrap around neighbouring tubules facilitat-
ing an intimate relationship with the cells of these tubules. A
3D reconstruction of Fig. 3H showing this relationship can be
seen at http://kidney.scgap.org/files/CSF1_Supp_Data/3D_
reconstruction/Fig.%203H.avi.
Characterising expression profile of embryonic macrophage
populations
Macrophages of the developing embryo are known to have a
distinct gene expression profile compared to adult (Lichanska et
al., 1999; Lichanska and Hume, 2000). The EGFP marker, and
the comparative abundance of the EGFP-positive cells, makes it
feasible to sort the embryonic macrophages from individual
tissues to perform expression profiling. To address the question
of whether macrophages in particular organs perform an organ-
specific function, or adapt to a particular developmental niche,
we compared the profiles of resident embryonic kidney, lung
and brain EGFP-positive cells isolated from 15.5 dpc murine
embryos using FACS separation. The relative abundance of
macrophages was similar for all three tissues, with the EGFP-
positive population representing approximately 2–5% of the
total cells of all organs analysed (kidney shown in Fig. 3L) at
15.5 dpc. Initial expression profiling using 16,000 elementCompugen oligonucleotide arrays was performed as a direct
three-way comparison between E15.5 kidney-derived, lung-
derived and brain-derived GFP-positive cells in order to
determine the homogeneity of the resident embryonic mono-
cytic phenotype at this time point. The primary data for these
experiments can be viewed using BASE at http://kidney.scgap.
org/base (username: devbiolreviewer; password: csf1). The data
has also been placed on GEO (Accession no. GSE6271). A
complete table showing the results of can be found at http://
kidney.scgap.org/CSF1_Supp_Data/Macrophage_summary/
Supp_table1.xls. An analysis of the genes identified as
distinguishing between any two populations revealed that the
only differences seen represented genes known to be highly
specific for the organ of origin. Hence, kidney outliers
compared to brain and lung included cadherin 16 and WT1,
both known to be highly enriched in kidney. Similarly, outliers
in brain included the microtubule-associated protein tau, tubulin
alpha 1 and neuronatin while outliers in lung included
surfactant protein C and fibrillin 1. This implied that the only
significant differences between resident embryonic macro-
phages resulted from minor contamination with the source
tissue or the presence of RNA from other cells types in
macrophages post phagocytosis.
To verify the similarity in expression pattern of resident
embryonic macrophages from different tissues, expression
profiling of kidney versus EGFP-enriched kidney macrophages,
brain versus brain macrophages and lung versus lung macro-
phages was performed using 16,000 element Compugen
oligonucleotide arrays. This analysis was internally validated
in each case by the fact that the Csf1r mRNA was enriched in
the EGFP-positive population. A complete table showing the
results of can be found at http://kidney.scgap.org/CSF1_Supp_
Data/Macrophage_summary/Supp_table2.xls. The primary data
for these experiments can be viewed using BASE at http://
kidney.scgap.org/base (username: devbiolreviewer; password:
csf1; GEO Accession no. GSE6271). Table 1 lists the 50 genes
showing the highest enrichment ratio comparing the EGFP-
enriched and parent tissue in each of the organs analysed. The
relative enrichment of Csf1r expression itself was 5.4-, 2.8- and
7.6-fold in the kidney, lung and brain, respectively. This
unexpectedly low enrichment may suggest that Csf1r mRNA is
expressed, albeit at much lower levels than in macrophages, in
other cells of the kidney. Table 2 lists the 50 genes for which the
statistical confidence of the differential gene expression (B-
statistic) was highest. For all three macrophage populations,
Csf1r showed a B-score in the top 50 (6.97, 3.72, 6.64 for
kidney, lung and brain) demonstrating that the FACS-based
enrichment for cells expressing this gene is highly robust (B-
score of N0 is statistically significant). The gene expression
analysis performed on the three resident macrophage popula-
tions showed extremely high concordance (Tables 1 and 2).
There were no genes that were unequivocally enriched in the
EGFP-positive fraction in any one organ compared to another
suggesting that the foetal macrophage phenotype is very similar
between organs. In contrast, the genes enriched in the parent
tissues (kidney, lung, and brain) were clearly tissue-specific as
would be expected (see Table 1, right panel).
Table 1
A comparison of the genes demonstrating the highest fold change between macrophage and tissue of origin
The macrophage-enriched genes with the highest fold change from kidney, brain and lung macrophages are listed in columns 1, 2 and 3, respectively. A visual comparison of columns 1–3 illustrates the high degree
of concordance between the gene expression of resident macrophages in all tissues (columns 1–3). In contrast, the genes showing enrichment in the kidney as tissue of origin (column 4) show no concordance with
those enriched in lung and brain. Red indicates higher relative expression in macrophages. Green demonstrates higher relative expression in host tissue. Genes common to 2 /3 lists are highlighted in pale yellow.
Genes common to all three lists are shown in bright yellow. UGI name is listed for each gene where available. If there is no gene name, an accession number is listed.
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Table 2
A comparison of the genes demonstrating the highest B-score change between macrophage and tissue of origin, indicating those gene for which there is the highest
statistical confidence of an enrichment in one population versus another
The macrophage-enriched genes with the highest B-score from kidney, brain and lung macrophages are listed in columns 1, 2 and 3, respectively. A visual comparison
of columns 1–3 illustrates the high degree of concordance between resident macrophages in all tissues. Red indicates higher confidence of enrichment in macrophages.
Green demonstrates higher confidence of enrichment in host tissue. Genes common to 2/3 lists are highlighted in pale yellow. Genes common to all three lists are shown in
bright yellow.
240 F. Rae et al. / Developmental Biology 308 (2007) 232–246The results of this profiling showed that many well
characterised macrophage-specific and macrophage-associated
genes were represented amongst the outliers for the EGFP-
enriched macrophage populations. This included the macro-
phage transcription factor, PU.1 (sfpi1), the F4/80 antigen
(EMR1), and lysozyme, all shown to have similar distributions
to Csf1r in whole mount in situ hybridization profiles
(Lichanska et al., 1999). Other macrophage genes expressed
include chemokine (C–C) and (C–X–C) ligands (including
CXCL1, CXCL2, CCL2, CCL4, CCL6, CCL7, CCL9, CCL12,
CCL24) and receptors (including CX3CR1, which waspreviously used a marker for yolk-sac-derived macrophages),
as well as many membrane receptors that are commonly used as
definitive macrophage markers (sialoadhesin, Mac1, F4/80
(EMR-1, EGF-like module containing, mucin-like, hormone
receptor-like sequence)). By extension, the significant numbers
of unannotated genes on these lists are likely to be macrophage
functional genes. Section RNA in situ hybridization was
performed on N20 genes with enriched expression in renal
macrophages. The expression patterns depicted in Fig. 4
validate both the isolation and profiling data. Csf1r was
detected by RNA in situ hybridization suggested an expressing
Fig. 4. Localization of genes enriched in kidney macrophages. RNA in situ
hybridisation of E15.5 kidneys showed expression in the medullary regions
for (A) Csf1r (c-fms) and (B) macrophage scavenger receptor 1 (Msr1), whereas
(C) Glycoprotein 49B (Gp49b) possibly marked a smaller subset of macro-
phages located at the corticomedullary junction of the kidney. (D) Lysosomal-
associated protein transmembrane 5 (Laptm5) was not exclusively expressed
in macrophages. Punctate expression was also seen in tubules, glomeruli and
interstitium. Scale bar=100 μm.
241F. Rae et al. / Developmental Biology 308 (2007) 232–246population consistent with the 2–5% indicated following FACS
analysis (Fig. 4A). Macrophage scavenger receptor 1 (Msr1)
marked an apparently identical population of macrophages (Fig.
4b). Glycoprotein 49B (Gp49b) appeared to mark a smaller
subset of macrophages at the corticomedullary junction of thekidney (Fig. 4c). Such subpopulations may represent different
types of cells or different stages of monocytic maturation, as has
been shown previously during in mouse embryos for markers
such as F4/80 which first appears later in development than
csf1r (Lichanska et al., 1999).
Effects of CSF-1 in kidney explant culture and changes in gene
expression
The traditional view of macrophage function in the embryo is
phagocytic clearance of dying cells (Henson and Hume, 2006).
In contrast, a trophic role has been implied in many adult tissues
undergoing regeneration (Pull et al., 2005). In a recent study of
the role of macrophages in pancreatic development in mice,
Geutskens et al. (2005) noted that their numbers continued to
increase in organ culture, suggesting an autonomous prolif-
erative activity, and that they could be expanded further with ex
vivo treatment of organ cultures with CSF-1. We therefore asked
whether CSF-1 could increase macrophage numbers in the
kidney, and whether there would be a consequential modulation
of renal development. 100 U/μl human recombinant CSF-1 was
added to kidney explant culture to determine its effects on
branching and nephron formation. The effects of CSF-1 alone as
a stimulus were inconsistent across experiments. We considered
the possibility that there is an endogenous ligand that acts in
concert with CSF-1, by analogy with RANKL in the
differentiation of osteoclasts (Blair et al., 2005) and our data
showing that CSF-1 acts in concert with lipopolysaccharide
(LPS) (Sweet et al., 2002). LPS alone had no effect on
differentiation of explanted kidneys; however, addition of low
concentrations of LPS permitted a consistent response to CSF-
1. Development was assessed by immunofluorescence for
calbindin 28 kDa and WT1 to highlight the development of the
branching ureteric tree and developing nephrons respectively
(Fig. 5A). Addition of CSF-1 to explanted 11.5–12.0 dpc
kidneys resulted in a statistically significant increase in the
number of branch tips and nephrons after 4 days in culture
(Fig. 5B).
To identify the molecular changes that occur after the
addition of CSF-1, expression profiling was performed on CSF-
1-treated explants compared with untreated explants. The 50
highest ranked genes based on a fold-change and B-statistic are
shown in Table 3. Seventeen of the top 20 outliers upregulated
(based on fold-change) in CSF-1-treated explants were also
found to be upregulated (based on fold change) in the resident
renal macrophage list, indicating that CSF-1 specifically
upregulates macrophage genes, most likely by increasing the
number of macrophages present during culture. 11.5 dpc
explants from Csf1r–ECFP mice were cultured with or without
the addition of CSF-1 (Figs. 5Ai, j), the increased apparent
abundance of ECFP-positive cells confirming an increase in the
macrophage population in the CSF-1-treated explants. The
upregulation of calbindin 28 kDa, which is encoded specifically
by the developing ureteric tree, shows a disproportionate
increase in tree branching, suggesting that the primary event is a
stimulation of ureteric branching followed by an increase in
formation of nephron condensates.
Fig. 5. (A) Metanephric explant culture of 11.5 dpc kidneys cultured with CSF-1 (100 U/ml)+LPS (0.1 ng/ml) (b, d, f, h, j) or LPS alone (control; a, c, e, g, i) explants.
Explants were cultured for 1 (a, b), 2 (c, d), 3 (e, f), 4 (g, h) or 5 days (i, j). In panels a–h wild-type mice were used and immunofluorescence was performed to reveal
the ureteric tree (calbindin-D28K, green), forming nephrons (WT1, red) and all nuclei (DAPI, blue). In panels i and j, Csf1r–ECFP mice were used and the blue
fluorescence show the CFP-positive macrophages present in the cultures. (B) Total numbers of ureteric tree branches, ureteric tips and condensates in control versus
CSF-1-treated explants at 1 day (a), 2 days (b) and 3 days (c) of culture. Error bars represent the standard deviation of the mean for one representative experiments.
Experiments were performed at least twice for each time point. Asterisks indicate where there is a significant different (pb0.05) between control and CSF-1-treated
explants.
242 F. Rae et al. / Developmental Biology 308 (2007) 232–246A number of genes upregulated in explants in response to
CSF-1 were predicted to encode secreted proteins, including
chemokines. We investigated whether these chemokines were
responsible, alone or in combination, for some of the trophic
roles of CSF-1. Unlike CSF-1, the addition of recombinant
CCL9, CCL4, CCL4+CCL9, CCL6, Cxcl1 or Gas6 showed no
visible or significant effect on kidney explant development
(data not shown).
An analysis of the genes marking embryonic macrophages in
general and also genes induced in response to culture of
explants in CSF-1 showed a link with the alternate or M2
pathway of macrophage activation. The alternate activation
pathways have been implicated in an anti-inflammatory, pro-
proliferative role for macrophages. A modified version of the
M2 response occurs in tumour-associated macrophages (Man-
tovani et al., 2004), suggesting that this may be important for
the trophic role played by macrophages in tumours. The M2
pathway is classically induced in response to IL-4 and IL-3 and
results in the upregulation of IL-10 and TGFβ (Mantovani et al.,2004; Sica et al., 2006). While these genes were not
overrepresented in embryonic macrophages or upregulated in
response to CSF-1, a number of M2-associated genes identified
in tumour-associated macrophages were present on embryonic
macrophages, including macrophage mannose receptor, macro-
phage scavenger receptors 1 and 2 (Msr1, Msr2), CCL24 and
C1q. Van Ginderachter et al. (2006) suggest that the M2
response ex vivo during different pathologies is characterised by
the expression of genes linked to wound healing and
angiogenesis, including selenoprotein P and TREM2. Both of
these genes were enriched in resident embryonic macrophages
and Trem2 was strongly induced in explants in response to
CSF-1 (see Tables 1–3 and http://kidney.scgap.org/CSF1_
Supp_Data/Macrophage_summary/Supp_table1.xls). Trem2
appears to attenuate the production of cytokines associated
with classical activation (Turnbull et al., 2006). A more recent
analysis of the transcriptome of human monocytes during
differentiation and polarization highlighted a set of genes
differentially expressed in M2 macrophages (Martinez et al.,
Table 3
Genes induced in embryonic kidney explants in response to the addition of CSF-1, as assessed by fold change and B-statistic
The top 50 genes enriched in explants in response to CSF-1 treatment are depicted based on fold change (right) and B-score (left). Yellow shading indicates those
genes overlapping with the macrophage enriched genes in Tables 1 and 2.
243F. Rae et al. / Developmental Biology 308 (2007) 232–2462006). This included CD36, cathepsin C and selenoprotein P1,
which are all strongly expressed in GFP-positive cells from all
three organs examined.
Discussion
This study provides the first comprehensive overview of the
infiltration of the developing embryo by macrophages detected
with a convenient EGFP reporter gene, examines their
molecular phenotype, and sheds light on their possible function
in kidney development.
The majority of the literature on macrophages in embryonic
development focuses on their role in removal of apoptotic cell
bodies. This is certainly a major activity, and one that is
conserved from Drosophila through to mammals (Henson andHume, 2006). Several receptors are likely to be involved in this
recognition process, including abca1 (conserved from Droso-
phila), the macrophage scavenger receptor, the phosphatidyl
serine receptor and CD36. All of these genes, and many others
(macrophage mannose receptor, C1q, Msr2, galectin 1, galec-
tin 3, galectin 9, SRB2, C1q, C type lectins Clec4a2, 4a3, 7a,
4n, Gas6), as well as several lysosomal hydrolases and
lysosome-associated proteins (LAMPs, CD68) were enriched
in the Csf1r–EGFP-positive embryonic macrophages (Tables 1
and 2). This extensive repertoire may explain why the knockout
of individual receptors does not appear to impair the removal of
dead cells. In fact, in at least some sites in the body, the removal
of apoptotic cells can be carried out by “facultative” phagocytes
(neighbouring mesenchymal cells) in animals that lack normal
macrophage populations due to mutation in the PU.1 gene
244 F. Rae et al. / Developmental Biology 308 (2007) 232–246(Wood et al., 2000). These animals are not deficient in yolk-sac-
derived macrophages, which might provide some essential
phagocyte functions (Lichanska et al., 1999).
The trophic function of macrophages is implied from the
substantive growth deficiency in animals that have mutations in
either CSF-1, or the CSF-1 receptor (Dai et al., 2002). In addition
to global growth defects, some organs that are especially affected
include bone, the sensory nervous system, gonads, mammary
gland and pancreas (Banaei-Bouchareb et al., 2004; Cohen et al.,
1996; Michaelson et al., 1996; Van Nguyen and Pollard, 2002).
These developmental abnormalities may reflect a physiological
role for CSF-1 itself, since the levels of CSF-1 mRNA and
protein increase with gestational age and exhibit a postnatal
spike (Roth and Stanley, 1996). The absence in CSF-1-deficient
mice of definitive loss of function or apparent structural
disturbance in other organs should not be taken as evidence
that the macrophage role is dispensable. Macrophages detected
using the F4/80 marker (which is itself CSF-1-sensitive;
Carninci et al., 2006; Hume et al., 1988) (see also www.
macrophages.com) are not completely depleted in any organ of
the CSF-1 or Csf1r-deficient mouse lines. In the former case,
CSF-1 may be derived from the maternal circulation if the
mother is heterozygous (Roth et al., 1998). The effect of the
Csf1r mutation is more penetrant, presumably because it cannot
be overcome by CSF-1 from the mother (Dai et al., 2002).
Monocytes that tune inflammatory responses, scavenge
debris, promote angiogenesis and tissue remodelling and repair
have been referred to as M2 macrophages (Gordon and Taylor,
2005; Mantovani et al., 2004; Wilson et al., 2004), extending a
rather imperfect analogy with the Th1/Th2 helper T cell
dichotomy. The macrophages found within tumours probably
constitute a novel subclass of these so-called M2 macrophages
(Biswas et al., 2006; Mantovani et al., 2005; Sica et al., 2006).
The phenotype of the embryonic macrophages characterised
herein overlaps with the published tumor-associated macro-
phage data, in particular overlapping the chemokine (e.g.
CCL2) and receptor (galectin 1, scavenger receptor A, msr2,
C1q, mannose receptor) markers highlighted by others
(Mantovani et al., 2004). This phenotype in tumour-associated
macrophages has recently led to a novel approach to cancer
therapy, involving immunisation against legumain, the lysoso-
mal asparaginyl endopeptidase (Luo et al., 2006), which is also
enriched in embryonic macrophages. Taken together, the data
suggest that there are significant similarities between the foetal
and tumour environments that lead to common macrophage
phenotype. By extension, the macrophages in the tumours and
embryos are likely to share trophic mechanisms, and an
understanding of the roles of macrophages in embryogenesis
may be translated into therapeutic applications in malignancy.
In the current study, we have added the kidney to the list of
organs whose growth is positively affected by resident
embryonic macrophages. The addition of CSF-1 to explanted
developing kidneys elicited a remarkable increase in rate of
development. There are several ways by which CSF-1 may
generate a trophic effect on the developing kidney. The first is
the possibility that the macrophages respond to CSF-1 signaling
via the production of one or more critical factors that enhancerenal development. These may involve secreted factors or a
growth signal mediated by surface tethered or transmembrane
proteins able to signal to adjacent renal cells. The ability of
several individual chemokines to mimic CSF-1 was eliminated,
but a complex milieu may be required. The second possibility is
a net increase in the clearance of apoptotic cells due to
stimulation of the macrophages. The profiling of explants±
CSF-1 did not reveal significant changes in apoptotic markers
that would support this. The third option is that CSF-1, simply
by increasing the number of resident macrophages, enhances
the proliferative milieu being provided by these cells. The
similarity between the profile of resident macrophages and
tumour-associated macrophages would support this concept.
Finally, there might be direct signalling by CSF-1 to another cell
population within the kidney. This possibility is supported by
the relatively low apparent enrichment for Csf1r expression that
was seen when comparing embryonic macrophages with their
resident tissue. While in situ hybridization and analysis of the
Csf1r transgenics themselves did not suggest the existence of
any other Csf1r-positive cells, it is possible that there is
widespread low levels of Csf1r expression throughout the
kidney which may transduce the CSF-1 response. However, our
observations of an intimate relationship between the resident
renal macrophage and the developing renal tubules, coupled
with the observed response of the developing kidney to CSF-1,
suggests a niche-like relationship between macrophage and
tubule that may be critical for repair. Indeed, the major sites of
CSF-1 production within the damaged kidney are the tubular
epithelial cells themselves (Isbel et al., 2001). A similar niche
has been recently shown for the resident macrophage in the
colonic crypts (Pull et al., 2005).
An analysis of the secreted proteins being produced by
embryonic macrophages reveals many C–C and CXC motif
chemokine ligands known to play roles in directed migration,
activation and proliferation. The expression of receptors for Ccl
and Cxcl chemokines on renal cells, including podocytes and
collecting duct cells (Le Meur et al., 2004), suggests that these
ligands can signal to the kidney itself rather than simply playing
a role in monocyte attraction. Transferrin is a major plasma iron-
completing protein made by peritoneal macrophages and the
liver that transports ferric iron to all tissues (Yang et al., 1990).
Its presence within serum-free culture media has long been
shown to be essential for organ culture (Avner et al., 1985;
Ekblom and Thesleff, 1985). In combination with insulin,
transferrin enhances cell proliferation in cultures of human fetal
kidney (Briere et al., 1991) and potentiates the activity of EGF
on mitogenesis (Chailler et al., 1991). The source of renal
transferrin ex vivo has not previously been investigated. Our
data show that one source of renal transferrin is the resident
macrophage.
The existence of monocyte-derived cells within the adult
kidney has recently been reported using a CX3CR1-transgenic
line. These cells were referred to as dendritic cells (DCs) and
suggested to play an immune sentinel role in the post-natal
kidney (Soos et al., 2006). As noted previously, CX3CR1 is also
a marker of yolk-sac-derived phagocytes (Bertrand et al.,
2005b). In concordance with our data, the network of CX3CR1-
245F. Rae et al. / Developmental Biology 308 (2007) 232–246positive cells within the kidney lay within the interstitium with
close proximity to the tubular cells (Soos et al., 2006), however
they also observed cells in the mesangium. Occasional EGFP-
positive cells were observed in the adult vascular pole of the
Csf1r–EGFP transgenic glomeruli, but these appeared to be
circulating blood monocytes based upon number, position and
morphology (data not shown). Our observations of a trophic
role for macrophages (or DCs) during development supports an
alternate view to that proposed by Soos et al. (2006). Rather
than being an immunological sentinel, we propose that these
cells may continue to play a trophic and possibly regenerative
role in the postnatal kidney.
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